These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1503094)

  • 1. Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia.
    Smalley RV; Connors J; Tuttle RL; Anderson S; Robinson W; Whisnant JK
    Am J Hematol; 1992 Sep; 41(1):13-8. PubMed ID: 1503094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.
    Smalley RV; Anderson SA; Tuttle RL; Connors J; Thurmond LM; Huang A; Castle K; Magers C; Whisnant JK
    Blood; 1991 Dec; 78(12):3133-41. PubMed ID: 1742480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
    Shibata T; Hotta T
    Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
    Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
    Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hairy cell leukaemia: the role of alpha interferon.
    Platanias LC; Ratain MJ
    Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
    Troussard X; Flandrin G
    Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
    Capnist G; Federico M; Chisesi T; Resegotti L; Pagnucco G; Castoldi GL; Lamparelli T; Frassoldati A; Guarnaccia C; Leoni P
    Leuk Res; 1991; 15(6):419-26. PubMed ID: 1861528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy.
    Ratain MJ; Vardiman JW; Barker CM; Golomb HM
    Cancer; 1988 Dec; 62(11):2420-4. PubMed ID: 3179961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon in the treatment of hairy-cell leukemia.
    Ahmed S; Rai KR
    Best Pract Res Clin Haematol; 2003 Mar; 16(1):69-81. PubMed ID: 12670466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ; Vardiman JW; Golomb HM
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
    Golomb HM; Jacobs A; Fefer A; Ozer H; Thompson J; Portlock C; Ratain M; Golde D; Vardiman J; Burke JS
    J Clin Oncol; 1986 Jun; 4(6):900-5. PubMed ID: 3519880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis.
    Damasio EE; Clavio M; Masoudi B; Isaza A; Spriano M; Rossi E; Casciaro S; Cerri R; Risso M; Nati S; Siccardi M; Truini M; Gobbi M
    Eur J Haematol; 2000 Jan; 64(1):47-52. PubMed ID: 10680705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
    Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
    Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
    J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
    Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
    J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia. Current management.
    Doane LL; Ratain MJ; Golomb HM
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):489-502. PubMed ID: 2182604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.